Piloting international production of rapid relative effectiveness assessments of pharmaceuticals

Dario Sacchini, Sarah Kleijnen, Iris Pasternack, Piia Rannanheimo, Jenni M. Vuola, Marc Van De Casteele, Anna Bucsics, Isabelle Zahra Pulis, Simona Montilla, Payam Abrishami, Sylvana Magrin Sammut, Luisa Anna Adele Muscolo, Pertti Happonen, Wim G. Goettsch

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


A pilot assessment was conducted to test the first version of the HTA Core Model and the draft Guidelines for Rapid relative effectiveness assessment (REA) of pharmaceuticals, as well as the capacity for international collaboration required to produce an assessment. The aim of the present study was to describe and analyze the lessons learned from the pilot project based on input from three different perspectives: the assessors, the users (HTA organizations) and the marketing authorization holder (MAH). This article does not address the scientific quality of the pilot report.
Original languageEnglish
Pages (from-to)521-529
Number of pages9
JournalInternational Journal of Technology Assessment in Health Care
Publication statusPublished - 2014


  • Inglese


Dive into the research topics of 'Piloting international production of rapid relative effectiveness assessments of pharmaceuticals'. Together they form a unique fingerprint.

Cite this